MAOB and Parkinson disease: This possibility has been tested in the rodent models of PD, including the MPTP mouse model, 6-OHDA rat model, and viral overexpression of A53T-mutated alpha-synuclein mouse model by a pharmacological blockade, gene-silencing, and genetic ablation of MAOB [21,22,41].